Docuvera for Aggregate Reporting and Safety Writing improves quality and consistency of pharmacovigilance documentation across all stages of the product lifecycle

Ongoing pharmacovigilance is essential to the development of safe medicines, required to introduce them into the market and ensures their survival in the market once approved. However, because authoring and management of aggregate reports represents one of the most time and resource intensive pharmacovigilance regulatory requirements, pharmaceutical companies are exceedingly interested in technology solutions that help to alleviate this burden. Unfortunately, the traditional approach to authoring and managing aggregate reports via a document metaphor does nothing to reduce the burden on authors or facilitate reuse of information across safety documents.

Docuvera Aggregate Reporting-cover.jpg